# Gene Transfer for Patients With Sickle Cell Disease

> **NCT02186418** · PHASE1,PHASE2 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 7 (actual)

## Conditions studied

- Anemia, Sickle Cell

## Interventions

- **GENETIC:** ARU-1801

## Key facts

- **NCT ID:** NCT02186418
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Sponsor decision due to funding
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02186418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02186418, "Gene Transfer for Patients With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02186418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*